High
39.960
Open
38.950
VWAP
39.10
Vol
1.46M
Mkt Cap
14.11B
Low
38.548844
Amount
57.12M
EV/EBITDA(TTM)
14.07
Total Shares
359.88M
EV
21.74B
EV/OCF(TTM)
--
P/S(TTM)
3.51
The Carlyle Group Inc. is a global investment company. The Company operates through three segments: Global Private Equity, Global Credit, and Global Investment Solutions. The Global Private Equity segment advises the Company’s buyout, middle market and growth capital funds, its U.S. and internationally focused real estate funds, and its infrastructure and natural resources funds. The segment also includes the NGP Carry Funds advised by NGP. The Global Credit segment advises funds and vehicles that pursue investment strategies including loans and structured credit, direct lending, opportunistic credit, distressed credit, aircraft financing and servicing, infrastructure debt, insurance solutions and global capital markets. The Global Investment Solutions segment advises global private equity programs and related co-investment and secondary activities. The Company has investment professionals in over 28 offices across four continents. It also focuses on private student loan portfolio.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
966.17M
-5.56%
0.951
-5.83%
961.16M
+21.84%
0.914
+17.15%
1.02B
+14.44%
0.982
+3.4%
Estimates Revision
The market is revising Downward the revenue expectations for The Carlyle Group Inc. (CG) for FY2025, with the revenue forecasts being adjusted by -3.51% over the past three months. During the same period, the stock price has changed by -31.34%.
Revenue Estimates for FY2025
Revise Downward

-3.51%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-5.13%
In Past 3 Month
Stock Price
Go Down

-31.34%
In Past 3 Month
11 Analyst Rating

13.30% Upside
Wall Street analysts forecast CG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CG is 44.30 USD with a low forecast of 37.00 USD and a high forecast of 55.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
9 Hold
1 Sell
Hold

13.30% Upside
Current: 39.100

Low
37.00
Averages
44.30
High
55.00

13.30% Upside
Current: 39.100

Low
37.00
Averages
44.30
High
55.00
Morgan Stanley
Michael Cyprys
Hold
Maintains
$57 → $44
2025-04-14
Reason
Morgan Stanley
Michael Cyprys
Price Target
$57 → $44
2025-04-14
Maintains
Hold
Reason
TD Cowen
Bill Katz
Hold
Maintains
$54 → $37
2025-04-09
Reason
TD Cowen
Bill Katz
Price Target
$54 → $37
2025-04-09
Maintains
Hold
Reason
JMP Securities
Devin Ryan
Buy
Maintains
$62 → $58
2025-04-08
Reason
JMP Securities
Devin Ryan
Price Target
$62 → $58
2025-04-08
Maintains
Buy
Reason
Citigroup
Christopher Allen
Hold
Maintains
$55 → $39
2025-04-08
Reason
Citigroup
Christopher Allen
Price Target
$55 → $39
2025-04-08
Maintains
Hold
Reason
Wells Fargo
Michael Brown
Hold
Maintains
$48 → $39
2025-04-08
Reason
Wells Fargo
Michael Brown
Price Target
$48 → $39
2025-04-08
Maintains
Hold
Reason
Barclays
Benjamin Budish
Buy
Maintains
$55 → $43
2025-04-07
Reason
Barclays
Benjamin Budish
Price Target
$55 → $43
2025-04-07
Maintains
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Carlyle Group Inc (CG.O) is 10.00, compared to its 5-year average forward P/E of 11.22. For a more detailed relative valuation and DCF analysis to assess Carlyle Group Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
11.22
Current PE
10.00
Overvalued PE
13.98
Undervalued PE
8.46
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
Undervalued EV/EBITDA
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
3.67
Current PS
3.42
Overvalued PS
4.44
Undervalued PS
2.90
Financials
Annual
Quarterly
FY2024Q4
YoY :
-519.65%
927.00M
Total Revenue
FY2024Q4
YoY :
-130.49%
253.60M
Operating Profit
FY2024Q4
YoY :
-133.91%
227.30M
Net Income after Tax
FY2024Q4
YoY :
-129.69%
0.57
EPS - Diluted
FY2024Q4
YoY :
-260.06%
-379.50M
Free Cash Flow
FY2024Q4
YoY :
+17.32%
83.20
Gross Profit Margin - %
FY2024Q4
YoY :
-376.38%
-20.48
FCF Margin - %
FY2024Q4
YoY :
-192.18%
24.52
Net Margin - %
FY2024Q4
6.82
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 5913.72% over the last month.
Sold
0-3
Months
811.0M
USD
3
3-6
Months
317.6M
USD
7
6-9
Months
9.2M
USD
10
0-12
Months
96.8M
USD
30
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 327.67% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
2.7M
Volume
4
6-9
Months
0.0
Volume
0
0-12
Months
2.3M
Volume
6
Bought
0-3
0
0.0
Volume
Months
3-6
5
2.5M
Volume
Months
6-9
0
0.0
Volume
Months
0-12
6
575.6K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
32.5K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
375.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 5913.72% over the last month.
Sold
0-3
Months
811.0M
USD
3
3-6
Months
317.6M
USD
7
6-9
Months
9.2M
USD
10
0-12
Months
96.8M
USD
30
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
CG News & Events
Events Timeline
(ET)
2025-04-24
09:25:23
Socially Determined, Acentra Health partner for enhanced analytics

2025-04-04 (ET)
2025-04-04
14:30:45
Backstone, Carlyle-backed Medline postpones IPO, FT reports


2025-03-28 (ET)
2025-03-28
13:49:38
TransDigm, PE firms among bidders for Boeing navigation unit, Reuters reports

Sign Up For More Events
Sign Up For More Events
News

Preview
9.5
04-25BenzingaBill Miller's Q4 Additions Struggle Amid Market Uncertainty, What Else Is Dragging Them Down?

Preview
8.0
04-24SeekingAlphaInvestors, executives need to know Trump's policy 'rule set,' Carlyle's Schwartz says

Preview
7.5
04-24GlobenewswireSocially Determined and Acentra Health Partner to Advance Whole Person, Whole Population Healthcare through Enhanced Analytics
Sign Up For More News
People Also Watch

EBF
Ennis Inc
17.840
USD
-0.45%

HUMA
Humacyte Inc
1.460
USD
+1.39%

OMER
Omeros Corp
7.270
USD
-0.55%

VZLA
Vizsla Silver Corp
2.210
USD
+1.84%

OPAL
Opal Fuels Inc
1.730
USD
-0.57%

EBS
Emergent BioSolutions Inc
5.450
USD
-0.73%

TMCI
Treace Medical Concepts Inc
6.900
USD
+2.68%

KULR
KULR Technology Group Inc
1.370
USD
+1.48%

NYMT
New York Mortgage Trust Inc
5.750
USD
+1.95%

CRNC
Cerence Inc
9.500
USD
-2.16%
FAQ

What is Carlyle Group Inc (CG) stock price today?
The current price of CG is 39.1 USD — it has increased 0.18 % in the last trading day.

What is Carlyle Group Inc (CG)'s business?

What is the price predicton of CG Stock?

What is Carlyle Group Inc (CG)'s revenue for the last quarter?

What is Carlyle Group Inc (CG)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Carlyle Group Inc (CG)'s fundamentals?

How many employees does Carlyle Group Inc (CG). have?
